| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
1,190,000 |
| Market
Cap: |
3.09(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$2.5846 - $15.75 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Avinger is a commercial-stage medical device company that designs, manufactures and sells real-time image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Co.'s proprieary image-guided Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion, and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
223 |
| Total Sell Value |
$0 |
$0 |
$0 |
$181 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Patel Himanshu |
Chief Technology Officer |
• – – |
2015-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,027 |
96,286 |
|
- |
|
| Simpson John B Ph D Md |
Executive Chairman |
• • • |
2015-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
41 |
41 |
|
- |
|
| Patel Himanshu |
Chief Technology Officer |
• – – |
2015-02-04 |
4 |
S |
$13.00 |
$22,503 |
D/D |
(1,731) |
95,259 |
|
- |
|
| Patel Himanshu |
Chief Technology Officer |
• – – |
2015-02-04 |
4 |
OE |
$12.60 |
$22,491 |
D/D |
1,785 |
96,990 |
|
- |
|
| Patel Himanshu |
Chief Technology Officer |
• – – |
2015-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
26,173 |
95,205 |
|
- |
|
| Cullen James |
Director |
– • – |
2015-02-04 |
4 |
S |
$13.00 |
$29,991 |
I/I |
(2,307) |
73,835 |
|
- |
|
| Cullen James |
Director |
– • – |
2015-02-04 |
4 |
OE |
$12.60 |
$29,988 |
I/I |
2,380 |
76,142 |
|
- |
|
| Cullen James |
Director |
– • – |
2015-02-04 |
4 |
A |
$0.00 |
$0 |
I/I |
86,863 |
73,762 |
|
- |
|
| Mcelwee James B |
Director |
– • – |
2015-02-04 |
4 |
S |
$13.00 |
$7,501 |
D/D |
(577) |
15,090 |
|
- |
|
| Mcelwee James B |
Director |
– • – |
2015-02-04 |
4 |
OE |
$12.60 |
$7,497 |
D/D |
595 |
15,667 |
|
- |
|
| Mcelwee James B |
Director |
– • – |
2015-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
15,072 |
15,072 |
|
- |
|
| Ferguson Matthew |
Chief Business Officer and CFO |
• – – |
2015-02-04 |
4 |
S |
$13.00 |
$15,002 |
D/D |
(1,154) |
13,827 |
|
- |
|
| Ferguson Matthew |
Chief Business Officer and CFO |
• – – |
2015-02-04 |
4 |
OE |
$12.60 |
$14,994 |
D/D |
1,190 |
14,981 |
|
- |
|
| Ferguson Matthew |
Chief Business Officer and CFO |
• – – |
2015-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
13,791 |
13,791 |
|
- |
|
| Lucas Venture Group Ix, Llc |
10% Owner |
– – • |
2015-02-04 |
4 |
S |
$13.00 |
$378,326 |
I/I |
(29,102) |
562,038 |
|
- |
|
| Lucas Venture Group Ix, Llc |
10% Owner |
– – • |
2015-02-04 |
4 |
OE |
$12.60 |
$378,315 |
I/I |
30,025 |
566,653 |
|
- |
|
| Lucas Venture Group Ix, Llc |
10% Owner |
– – • |
2015-02-04 |
4 |
A |
$0.00 |
$0 |
I/I |
584,344 |
561,115 |
|
- |
|
| Desai Arjun |
Chief Medical Officer |
• – – |
2015-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
358 |
358 |
|
- |
|
| Fogarty Thomas J M D |
Director |
– • – |
2015-02-04 |
4 |
A |
$0.00 |
$0 |
I/I |
277,777 |
277,777 |
|
- |
|
| John Bush Simpson & Rita Lynn Simpson, Trustees Of |
10% Owner |
– – • |
2015-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,207,821 |
1,264,289 |
|
- |
|
| Patel Himanshu |
Chief Technology OfficerOffice |
• – – |
2015-01-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
69,032 |
|
- |
|
| Simpson John B Ph D Md |
Director |
– • • |
2015-01-29 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
56,468 |
|
- |
|
247 Records found
|
|
Page 10 of 10 |
|
|
0.23 (7.96%) 
